Register Now
Course Information

Due to unforeseen circumstances, the course has been cancelled. We apologize for any inconvenience.


From fitness watches to robotic surgical assistance, artificial intelligence (AI) has changed the landscape of healthcare with real-time information and analysis that benefit patient outcomes. While AI is used to improve outcomes for patients in many areas, cardiovascular medicine is now a frontrunner in the AI revolution in medicine. This program explores the emerging technology of using artificial intelligence and machine learning in cardiovascular care, both its promise and potential pitfalls.

The faculty include experts and leaders from academia, government, and clinical practice to explore critical and emerging issues related to the impact of AI across the spectrum of health including early risk prediction and diagnosis of serious and complex heart problems. Content will be relevant to cardiovascular practitioners, researchers, and all healthcare and industry professionals interested in exploring the future of AI in patient care.

By attending, participants will be able to:

  • Define and describe the promise and potential risks of artificial intelligence use for preventing and managing cardiovascular disease. 
  • Appraise the role of machine learning and artificial intelligence within the continuum of other decision support and care delivery tools in providing quality patient care.
  • Critically appraise practical applications of precision AI, such as wearable devices, to help pinpoint patient-centered data in assessing and managing cardiovascular disease.
  • Analyze the clinical applications of AI imaging technology, such as 3D imaging MRI, and AI-enhanced options for clinicians to prevent, detect, and manage patients with CVD.
  • Describe novel strategies for precision AI in cardiovascular care including echocardiography, coupling AI-enhanced diagnoses with therapies and enhanced prediction algorithms.

Who should attend?

Physicians, scientists, researchers, industry and other professionals interested in the emerging technology of artificial intelligence and machine learning in the diagnosis and management of cardiovascular disease.